CTNM

Contineum Therapeutics
CTNM

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$21
75% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Faisal Khurshid
100% 1-yr CTNM win rate
25 Sep ‘25 23 days ago
Morgan Stanley
Morgan Stanley
Jeffrey Hung
67% 1-yr CTNM win rate
18 Aug ‘25 2 months ago